In this article, Robert A. Dowling, MD, describes some of the important differences and practical aspects of Stage 2 meaningful use as they related to "eligible professionals."
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.